CUFinder

David K. Simon

David K. Simon

Harvard University

H-index: 53

North America-United States

Contact David K. Simon

About David K. Simon

David K. Simon, With an exceptional h-index of 53 and a recent h-index of 32 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Movement Disorders.

His recent articles reflect a diverse array of research interests and contributions to the field:

Investigating the Indirect Interaction Between Vps35 and α-synuclein in Parkinson’s Disease (S26. 007)

Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials initiative

Genetic risk of Parkinson disease and progression

Dopamine transmission pathway and Parkinsons disease risk variants are associated with dyskinesia

Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea‐Acanthocytosis

A novel retromer stabilizer as a potential treatment for Parkinson’s disease (P14-11.016)

An Autopsy Series of Seven Cases of VPS13A Disease (Chorea‐Acanthocytosis)

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model

David K. Simon Information

University

Position

Beth Israel Deaconess Medical Center and Harvard Medical School

Citations(all)

12760

Citations(since 2020)

4932

Cited By

9295

hIndex(all)

53

hIndex(since 2020)

32

i10Index(all)

126

i10Index(since 2020)

72

Email

University Profile Page

Google Scholar

David K. Simon Skills & Research Interests

Movement Disorders

Top articles of David K. Simon

Investigating the Indirect Interaction Between Vps35 and α-synuclein in Parkinson’s Disease (S26. 007)

2024/4/14

David Simon
David Simon

H-Index: 27

Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials initiative

2024/4/5

Roger A Barker
Roger A Barker

H-Index: 75

Thomas Foltynie
Thomas Foltynie

H-Index: 66

Susan Fox
Susan Fox

H-Index: 44

J Timothy Greenamyre
J Timothy Greenamyre

H-Index: 51

David Sulzer
David Sulzer

H-Index: 63

Genetic risk of Parkinson disease and progression

Neurology Genetics

2024/3/20

Ganqiang Liu
Ganqiang Liu

H-Index: 13

Mathias Toft
Mathias Toft

H-Index: 26

Roger A Barker
Roger A Barker

H-Index: 75

Caroline H Williams-Gray
Caroline H Williams-Gray

H-Index: 37

Jacobus J Van Hilten
Jacobus J Van Hilten

H-Index: 54

Dopamine transmission pathway and Parkinsons disease risk variants are associated with dyskinesia

2023/8/30

Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea‐Acanthocytosis

Movement Disorders

2023/8

Kurt Farrell
Kurt Farrell

H-Index: 7

Brandon Barton
Brandon Barton

H-Index: 19

Alana Kirby
Alana Kirby

H-Index: 2

Karin Mente
Karin Mente

H-Index: 7

A novel retromer stabilizer as a potential treatment for Parkinson’s disease (P14-11.016)

2023/4/25

David Simon
David Simon

H-Index: 27

An Autopsy Series of Seven Cases of VPS13A Disease (Chorea‐Acanthocytosis)

Movement Disorders

2023/12

Kurt Farrell
Kurt Farrell

H-Index: 7

Brandon Barton
Brandon Barton

H-Index: 19

Alana Kirby
Alana Kirby

H-Index: 2

Karin Mente
Karin Mente

H-Index: 7

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model

Nature Communications

2023/11/13

Yu Sun
Yu Sun

H-Index: 8

Mark Kemp
Mark Kemp

H-Index: 6

Gabriel Balmus
Gabriel Balmus

H-Index: 12

Retromer stabilization using a pharmacological chaperone protects in an α-synuclein based mouse model of Parkinson’s

Research Square

2023/10/19

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential

2023/9/24

Li Gao
Li Gao

H-Index: 16

Zheng Han
Zheng Han

H-Index: 5

Wei Shi
Wei Shi

H-Index: 4

Yun Shen
Yun Shen

H-Index: 1

Mingming Su
Mingming Su

H-Index: 30

Qian Yang
Qian Yang

H-Index: 7

Yan Qu
Yan Qu

H-Index: 3

Bao Wang
Bao Wang

H-Index: 1

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia

medRxiv

2023/9/20

Alexey Kolodkin
Alexey Kolodkin

H-Index: 8

Patrick May
Patrick May

H-Index: 36

Jacobus J Van Hilten
Jacobus J Van Hilten

H-Index: 54

Lynne Krohn
Lynne Krohn

H-Index: 12

Eric Yu
Eric Yu

H-Index: 2

Pablo Mir
Pablo Mir

H-Index: 35

Ziv Gan-Or
Ziv Gan-Or

H-Index: 34

Trial of cinpanemab in early Parkinson’s disease

New England Journal of Medicine

2022/8/4

Anthony E Lang
Anthony E Lang

H-Index: 97

David J Brooks
David J Brooks

H-Index: 8

Kyle Fraser
Kyle Fraser

H-Index: 16

James Xiao
James Xiao

H-Index: 10

Associations between exercise classes and self-reported exercise by people with Parkinson’s disease at Parkinson’s foundation centers of excellence

Clinical Parkinsonism & Related Disorders

2022/1/1

Differences in the presentation and progression of Parkinson's disease by sex

Movement Disorders

2021/1

Ganqiang Liu
Ganqiang Liu

H-Index: 13

Mathias Toft
Mathias Toft

H-Index: 26

Roger A Barker
Roger A Barker

H-Index: 75

Jacobus J Van Hilten
Jacobus J Van Hilten

H-Index: 54

Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial

Jama

2021/9/14

Marian Evatt
Marian Evatt

H-Index: 17

Alberto Ascherio
Alberto Ascherio

H-Index: 89

Rebecca Fitzgerald
Rebecca Fitzgerald

H-Index: 50

Aleksandar Videnovic
Aleksandar Videnovic

H-Index: 27

Rajeev Kumar
Rajeev Kumar

H-Index: 3

Irene Litvan
Irene Litvan

H-Index: 62

Anwar Ahmed
Anwar Ahmed

H-Index: 19

Lin Zhang
Lin Zhang

H-Index: 9

Marie Saint-Hilaire
Marie Saint-Hilaire

H-Index: 25

Rajesh Pahwa
Rajesh Pahwa

H-Index: 47

Kathrin Lafaver
Kathrin Lafaver

H-Index: 17

Carmen Serrano
Carmen Serrano

H-Index: 14

Ivan Bodis-Wollner
Ivan Bodis-Wollner

H-Index: 23

Cinpanemab in early Parkinson's disease: phase 2 SPARK study results

Movement Disorders

2021/9

M Yang
M Yang

H-Index: 28

Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial

JAMA neurology

2021/3/1

Saurav Brahmachari
Saurav Brahmachari

H-Index: 16

Oren Levy
Oren Levy

H-Index: 23

Lin Zhang
Lin Zhang

H-Index: 9

Laura Ramirez
Laura Ramirez

H-Index: 4

Samuel Frank
Samuel Frank

H-Index: 3

Anwar Ahmed
Anwar Ahmed

H-Index: 19

Adolfo Ramirez-Zamora
Adolfo Ramirez-Zamora

H-Index: 18

Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study

Parkinsonism & related disorders

2021/2/1

Angela C Roberts
Angela C Roberts

H-Index: 12

Tom Davis
Tom Davis

H-Index: 5

Nabila Dahodwala
Nabila Dahodwala

H-Index: 26

Adolfo Ramirez-Zamora
Adolfo Ramirez-Zamora

H-Index: 18

David Simon
David Simon

H-Index: 27

Rajesh Pahwa
Rajesh Pahwa

H-Index: 47

Kelly Mills
Kelly Mills

H-Index: 10

Christopher Way
Christopher Way

H-Index: 8

John Morgan
John Morgan

H-Index: 1

Fernando Pagan
Fernando Pagan

H-Index: 15

Robert Hauser
Robert Hauser

H-Index: 57

Janis Miyasaki
Janis Miyasaki

H-Index: 43

Irene Litvan
Irene Litvan

H-Index: 62

VPS35 and the mitochondria: connecting the dots in Parkinson's disease pathophysiology

2020/11/1

Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advanced Parkinson's Disease

2020/4/14

David Simon
David Simon

H-Index: 27

See List of Professors in David K. Simon University(Harvard University)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine